Feds Investigate CVS Over Allegations of Missing Hydrocodone at California Pharmacies

View Comments (
)
|
Email
|
Print

    NEWSLETTERS

    TK
    Justin Sullivan
    Signs are posted outside of a CVS store in San Francisco, California. (Photo by Justin Sullivan/Getty Images)

    Federal officials are investigating CVS over tens of thousands of prescription pain killers that they say have gone missing from four of the company's California pharmacies, a newspaper reported.

    Roughly 37,000 hydrocodone tablets at CVS pharmacies in Fairfield, Turlock, Modesto and Dixon are unaccounted for, according to search-warrant affidavits reported by the Los Angeles Times on Monday.

    Hydrocodone -- found in such drugs as Vicodin -- is one of most widely-abused prescription drugs in the U.S.

    Lauren Horwood, a spokeswoman for the U.S. attorney's office in Sacramento, told the Times CVS is facing more than 2,900 possible violations of the federal Controlled Substances Act. The violations would carry a maximum fine of $29 million, she said.

    CVS spokesman Michael DeAngelis said the company regularly tells its pharmacists to maintain certain records and paperwork and recently sent them reminders. The company said in a statement it is "committed to working with the DEA."

    The investigations are aimed at "assuring compliance with state and federal requirements for administrative record keeping related to invoices and inventory for controlled substances,'' DeAngelis said.

    The investigation stems from a case involving a CVS store in Rocklin, northeast of Sacramento, where a pharmacy worker was accused in 2012 of hiding a bottle of hydrocodone in her pants, Brian Glaudel, an investigator for the U.S. Drug Enforcement Administration, said in an affidavit.

    DEA investigators discovered the other missing drugs after going over records for other CVS stores in the area, Glaudel said.

    Warrants were served at each of the four CVS stores last May, Casey Rettig, a special agent in the DEA's San Francisco office, told the Times. She declined further comment, the newspaper said.

     

    Statement from CVS:  

    We are committed to working with the DEA, other regulatory and enforcement agencies, as well as key stakeholders in the medical community, to combat prescription drug abuse and diversion. We are cooperating with the DEA in their review of pharmacy records at a few of our pharmacies in California to determine the reasons for the discrepancies in our record keeping and to correct them. As health care providers, our pharmacists and technicians remain focused on ensuring prescription drugs are only delivered to the patients who need them.

    CVS Caremark takes very seriously the challenge of combating prescription drug abuse and diversion, and we recognize the important role our pharmacists and technicians play on the front lines of solving this problem. As a company, we are investing significantly in internal controls and processes aimed at preventing prescription drug diversion from our pharmacies. For example, we are enhancing internal audit procedures to detect diversion, developing electronic controlled substance ordering and receiving systems, and implementing new storage and control measures for highly diverted controlled substances across all of our 7,600 stores.